Rx only · Capsule, Extended Release · Oral

Phendimetrazine Tartrate

1 ACTIVE SUPPLIER — US

openFDA · updated weekly

US1 NDCs
1 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATC—

RxCUI (US)58157

US makers1 labelers

Packages1

DEA / ScheduleCIII

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$3.287

Latest avg · Jul 22, 2026

+5%

Since Dec 17, 2025

Active US suppliers

100%

Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

Rx · 2026 Q1

2.8K

Units dispensed

+130%

Rx vs. year ago

Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Acertis Pharmaceuticals, LLC	unknown	1	SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.